Search results
US FDA expands GSK’s RSV vaccine approval to adults aged 50 to 59
WSAU Wausau· 6 days agoBy Sriparna Roy and Christy Santhosh (Reuters) -The U.S. Food and Drug Administration approved the...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks· 4 days agoFree Report) announced that the FDA has approved the expanded use of its respiratory syncytial virus (RSV) vaccine, Arexvy for adults aged 50-59 who are at increased risk ...
FDA clears GSK's RSV vaccine for adults ages 50-59
UPI· 5 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 1 day agoModerna reported that a single dose of mRNA-1083 met immunogenicity non-inferiority criteria versus...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 3 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
GSK (LON:GSK) Stock Price Crosses Above 200 Day Moving Average of $1,617.59
ETF DAILY NEWS· 2 days agoGSK plc (LON:GSK – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,617.59 ...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters· 6 days agoThe U.S. Food and Drug Administration approved the expanded use of GSK's respiratory syncytial virus...
GSK plc (NYSE:GSK) Shares Bought by Neuberger Berman Group LLC
ETF DAILY NEWS· 2 days agoNeuberger Berman Group LLC grew its stake in shares of GSK plc (NYSE:GSK – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Moderna COVID/flu combo vaccine superior to separate shots in trial
Reuters via Yahoo News· 3 days agoIn the study, the combination using messenger RNA technology generated greater antibodies than...
FDA gives nod to RSV vaccine for people in their 50s
Medical Xpress· 3 days agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since ...